JOYY:NSD-Infusive® Compounding Global Equities ETF (USD)

ETF | Others |

Last Closing

USD 41.17

Change

+0.44 (+1.08)%

Market Cap

N/A

Volume

0.25M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-0.39 (-0.72%)

USD 45.40B
QQQM Invesco NASDAQ 100 ETF

-0.05 (-0.03%)

USD 39.18B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.02 (+0.04%)

USD 22.49B
ACWI iShares MSCI ACWI ETF

+0.22 (+0.19%)

USD 19.99B
CGABL The Carlyle Group Inc. 4.625% ..

+0.07 (+0.41%)

USD 16.14B
SNDK Sandisk Corp

-0.58 (-1.77%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 5.43B
TSLL Direxion Shares ETF Trust - Di..

+0.09 (+0.86%)

USD 4.44B
NVDL GraniteShares 1.5x Long NVDA D..

-1.48 (-4.09%)

USD 3.04B
IBTF iShares iBonds Dec 2025 Term T..

+0.01 (+0.02%)

USD 2.18B

ETFs Containing JOYY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 69.56% 76% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.56% 75% C 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 0.85% 51% F 45% F
Dividend Return 2.62% 56% F 46% F
Total Return 1.77% 72% C 43% F
Risk Return Profile  
Volatility (Standard Deviation) 14.60% 41% F 84% B
Risk Adjusted Return 17.97% 40% F 54% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.